For example, glioblastoma-derived EVs enriched with CD73 upregulate adenosine levels, which binds to the adenosine receptor 2A on the surface of CD8 + T cells to inhibit glycolysis and TCA cycle. This evidence concerns the gene CD8A and glioblastoma.